These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18712951)

  • 1. Maternal thrombophilias are associated with specific placental lesions.
    Gogia N; Machin GA
    Pediatr Dev Pathol; 2008; 11(6):424-9. PubMed ID: 18712951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental fetal vascular thrombosis lesions and maternal thrombophilia.
    Beeksma FA; Erwich JJ; Khong TY
    Pathology; 2012 Jan; 44(1):24-8. PubMed ID: 22173239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report.
    Weber MA; Nikkels PG; Hamoen K; Duvekot JJ; de Krijger RR
    Pediatr Dev Pathol; 2006; 9(3):234-8. PubMed ID: 16944973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetric and perinatal complications in placentas with fetal thrombotic vasculopathy.
    Saleemuddin A; Tantbirojn P; Sirois K; Crum CP; Boyd TK; Tworoger S; Parast MM
    Pediatr Dev Pathol; 2010; 13(6):459-64. PubMed ID: 20438299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence.
    Katzman PJ; Genest DR
    Pediatr Dev Pathol; 2002; 5(2):159-64. PubMed ID: 11910510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis?
    Leistra-Leistra MJ; Timmer A; van Spronsen FJ; Geven WB; van der Meer J; Erwich JJ
    Placenta; 2004 Apr; 25 Suppl A():S102-5. PubMed ID: 15033316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is thrombophilia a risk factor for placental vascular disorders?].
    Borg JY
    Ann Med Interne (Paris); 2003; 154(5-6):325-31. PubMed ID: 15027586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilia and placental pathology.
    Redline RW
    Clin Obstet Gynecol; 2006 Dec; 49(4):885-94. PubMed ID: 17082683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent placental massive perivillous fibrin deposition associated with polymyositis: a case report and review of the literature.
    Al-Adnani M; Kiho L; Scheimberg I
    Pediatr Dev Pathol; 2008; 11(3):226-9. PubMed ID: 17990939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin.
    Katz VL; DiTomasso J; Farmer R; Carpenter M
    Am J Perinatol; 2002 Jul; 19(5):273-7. PubMed ID: 12152146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.
    Arias F; Romero R; Joist H; Kraus FT
    J Matern Fetal Med; 1998; 7(6):277-86. PubMed ID: 9848693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Massive perivillous fibrin deposition, chronic histiocytic intervillositis and villitis of unknown etiology: Lesions of the placenta at the fetomaternal interface with risk of recurrence].
    Feist H; Blöcker T; Hussein K
    Pathologe; 2015 Jul; 36(4):355-61. PubMed ID: 25613921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental pathology in fetal thrombophilia.
    Ariel I; Anteby E; Hamani Y; Redline RW
    Hum Pathol; 2004 Jun; 35(6):729-33. PubMed ID: 15188139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for thrombophilias: indications and controversies.
    Carbone JF; Rampersad R
    Clin Lab Med; 2010 Sep; 30(3):747-60. PubMed ID: 20638586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the fibrinolytic system of placentas with massive perivillous fibrin deposition.
    Uxa R; Baczyk D; Kingdom JC; Viero S; Casper R; Keating S
    Placenta; 2010 Jun; 31(6):499-505. PubMed ID: 20447686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of thrombophilia with fetal growth restriction.
    Jamal A; Hantoshzadeh S; Hekmat H; Abbasi S
    Arch Iran Med; 2010 Nov; 13(6):482-5. PubMed ID: 21039002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology of the placenta. Case 7. Massive perivillous fibrin deposits (maternal floor infarct)].
    Pelluard F
    Ann Pathol; 2010 Aug; 30(4):306-9. PubMed ID: 20837242
    [No Abstract]   [Full Text] [Related]  

  • 18. Massive perivillous fibrin deposition: Diagnosis, obstetrical features, and treatment.
    Cheloufi M; Coulomb A; Abisror N; Kayem G; Fain O; Alijotas-Reig J; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2024 Jan; 292():125-132. PubMed ID: 37995528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in long-chain 3-hydroxyacyl coenzyme a dehydrogenase are associated with placental maternal floor infarction/massive perivillous fibrin deposition.
    Griffin AC; Strauss AW; Bennett MJ; Ernst LM
    Pediatr Dev Pathol; 2012; 15(5):368-74. PubMed ID: 22746996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation disorders in pregnancy: acquired and inherited thrombophilias.
    Benedetto C; Marozio L; Tavella AM; Salton L; Grivon S; Di Giampaolo F
    Ann N Y Acad Sci; 2010 Sep; 1205():106-17. PubMed ID: 20840261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.